We are live on ! Find out more
LEXXW

Lexaria Bioscience Warrant
LEXXW

Delisted

LEXXW was delisted on the 13th of January, 2026.

Back to rankings

2 hedge funds and large institutions have $4.54K invested in Lexaria Bioscience Warrant in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

4.26% more ownership

Funds ownership: 0% → 4.26% (+4.3%)

0% more funds holding

Funds holding: 2 → 2 (0)

70% less capital invested

Capital invested by funds: $15K → $4.54K (-$10.4K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Heights Capital Management
California
$4.13K – – –
UBS Group
2
UBS Group
Switzerland
$420 – – –

LEXXW Hedge Fund Activity: Q2 2025 in Review

2 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q2 2025, worth a combined $4.54K — down 70% from $15K a quarter earlier.

Fund positioning in LEXXW was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $4.54K of Lexaria Bioscience Warrant stock for Q2 2025, down 70% quarter-over-quarter.
  • 0 funds opened new Lexaria Bioscience Warrant positions in Q2 2025 and 0 closed out.

Based on aggregated 13F filings for Q2 2025.